Literature DB >> 30240857

Craniopharyngiomas Primarily Involving the Hypothalamus: A Model of Neurosurgical Lesions to Elucidate the Neurobiological Basis of Psychiatric Disorders.

Jose María Pascual1, Ruth Prieto2, Inés Castro-Dufourny3, Lorenzo Mongardi4, Maria Rosdolsky5, Sewan Strauss6, Rodrigo Carrasco7, Laura Barrios8.   

Abstract

OBJECTIVE: This study provides a systematic review and meta-analysis of psychiatric disorders caused by craniopharyngiomas and the hypothalamic alterations underlying these symptoms.
METHODS: We investigated a collection of 210 craniopharyngiomas reported from 1823 to 2017 providing detailed clinical and pathologic information about psychiatric disturbances, including 10 of our own series, and compared the hypothalamic damage in this cohort with the present in a control cohort of 105 cases without psychiatric symptoms.
RESULTS: Psychiatric disorders occurred predominantly in patients with craniopharyngiomas developing primarily at the infundibulotuberal region (45%) or entirely within the third ventricle (30%), mostly affecting adult patients (61%; P < 0.001). Most tumors without psychic symptoms developed beneath the third ventricle floor (53.5%; P < 0.001), in young patients (57%; P < 0.001). Psychiatric disturbances were classified in 6 major categories: 1) Korsakoff-like memory deficits, 66%; 2) behavior/personality changes, 48.5%; 3) impaired emotional expression/control, 42%; 4) cognitive impairments, 40%; 5) mood alterations, 32%; and 6) psychotic symptoms, 22%. None of these categories was associated with hydrocephalus. Severe memory deficits occurred with damage of the mammillary bodies (P < 0.001). Mood disorders occurred with compression/invasion of the third ventricle floor and/or walls (P < 0.012). Coexistence of other hypothalamic symptoms such as temperature/metabolic dysregulation or sleepiness favored the emergence of psychotic disorders (P < 0.008). Postoperative psychiatric outcome was better in strictly intraventricular craniopharyngiomas than in other topographies (P < 0.001). A multivariate model including the hypothalamic structures involved, age, hydrocephalus, and hypothalamic symptoms predicts the appearance of psychiatric disorders in 81% of patients.
CONCLUSIONS: Craniopharyngiomas primarily involving the hypothalamus represent a neurobiological model of psychiatric and behavioral disorders.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amnesia; Apathy; Behavioral disturbances; Craniopharyngioma; Emotional disturbances; Hypothalamus; Psychiatric disorders

Mesh:

Year:  2018        PMID: 30240857     DOI: 10.1016/j.wneu.2018.09.053

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  8 in total

Review 1.  Guidelines for Treatment and Monitoring of Adult Survivors of Pediatric Brain Tumors.

Authors:  Anna J Janss; Claire Mazewski; Briana Patterson
Journal:  Curr Treat Options Oncol       Date:  2019-02-09

Review 2.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

Review 3.  Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases.

Authors:  Ruth Prieto; Laura Barrios; José M Pascual
Journal:  Neurosurg Rev       Date:  2021-08-27       Impact factor: 3.042

4.  Duct-like diverticulum at the base of third ventricle tumors: a morphological signature diagnostic of papillary craniopharyngioma.

Authors:  José María Pascual; Ruth Prieto; Rodrigo Carrasco; Laura Barrios
Journal:  Neurosurg Rev       Date:  2022-08-19       Impact factor: 2.800

5.  Craniopharyngioma and the Third Ventricle: This Inescapable Topographical Relationship.

Authors:  José María Pascual; Ruth Prieto
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

Review 6.  Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm.

Authors:  Francesco Calvanese; Timothée Jacquesson; Romain Manet; Alexandre Vasiljevic; Hélène Lasolle; Francois Ducray; Gerald Raverot; Emmanuel Jouanneau
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

7.  Hypothalamic injury patterns after resection of craniopharyngiomas and correlation to tumor origin: A study based on endoscopic observation.

Authors:  Le Yang; ShenHao Xie; Bin Tang; Xiao Wu; ZhiGao Tong; Chao Fang; Han Ding; YouYuan Bao; SuYue Zheng; Tao Hong
Journal:  Cancer Med       Date:  2020-11-03       Impact factor: 4.452

8.  Successful Diagnoses and Remarkable Metabolic Disorders in Patients With Solitary Hypothalamic Mass: A Case Series Report.

Authors:  Boni Xiang; Quanya Sun; Min He; Wei Wu; Bin Lu; Shuo Zhang; Zhaoyun Zhang; Yehong Yang; Yiming Li; Yue Wu; Zhenwei Yao; Haixia Cheng; Li Pan; Qing Miao; Yongfei Wang; Hongying Ye
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-16       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.